Oral leukoplakia: Diagnosis and treatment

Document Type: Review Article(s)

Authors

1 Department of Oral and Maxillofacial Surgery, Odense University Hospital, Odense, Denmark

2 Professor, Department of Plastic and Reconstructive Surgery, Odense University Hospital, Odense, Denmark

3 Professor, Department of ORL-Head and Neck Surgery, Odense University Hospital, Odense, Denmark

4 Associate Professor, Department of Oral and Maxillofacial Surgery, Odense University Hospital, Odense, Denmark

Abstract

BACKGROUND AND AIM: Oral leukoplakia (OL) is a common premalignant lesion. The possible benefits of specific interventions in preventing a malignant transformation of OL are not well understood. This review assesses different invasive treatment techniques for OL and evaluate the optimal treatment possibilities.METHODS: A Medline (PubMed) search was conducted and heterogeneity between the studies was found, e.g., with regard to the OL lesions, patient groups, follow-up time, and definition of recurrence.RESULTS: The recurrence and malignant transformation rate after the different treatment methods were evaluated. The mean overall recurrence rate varied with the treatment method.CONCLUSION: A surgical treatment appears to decrease the risk of transformation but does not fully eliminate it. Follow-up should be done regardless of the surgical treatment.

Keywords


  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62(1): 10-29.
  2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63(1): 11-30.
  3. NORDCAN, Association of the Nordic Cancer Registries. Cancer Statistics: Key figures [Online]. [cited 2014]; Available from: URL: https://www.cancer.dk/dyn/resources/File/file/7/3737/1400679130/nordcan-statistik-sygdomme-tunge.pdf. [In Danish].
  4. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, et al. Human papillomavirus and oral cancer: the international agency for research on cancer multicenter study. JNCI J Natl Cancer Inst 2003; 95(23): 1772-83.
  5. Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978; 46(4): 518-39.
  6. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007; 36(10): 575-80.
  7. Scully C, Porter S. ABC of oral health. Oral cancer. BMJ 2000; 321(7253): 97-100.
  8. Bhatnagar P, Rai S, Bhatnagar G, Kaur M, Goel S, Prabhat M. Prevalence study of oral mucosal lesions, mucosal variants, and treatment required for patients reporting to a dental school in North India: In accordance with WHO guidelines. J Family Community Med 2013; 20(1): 41-8.
  9. Einhorn J, Wersall J. Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa. Cancer 1967; 20(12): 2189-93.
  10. Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 1998; 34(4): 270-5.
  11. Sugar L, Banoczy J. Follow-up studies in oral leukoplakia. Bull World Health Organ 1969; 41(2): 289-93.
  12. Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984; 53(3): 563-8.
  13. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003; 14(1): 47-62.
  14. Lind PO. Malignant transformation in oral leukoplakia. Scand J Dent Res 1987; 95(6): 449-55.
  15. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 2000; 6(5): 1702-10.
  16. Nagao T, Ikeda N, Fukano H, Hashimoto S, Shimozato K, Warnakulasuriya S. Incidence rates for oral leukoplakia and lichen planus in a Japanese population. J Oral Pathol Med 2005; 34(9): 532-9.
  17. Petersen PE. Oral cancer prevention and control--the approach of the World Health Organization. Oral Oncol 2009; 45(4-5): 454-60.
  18. Patil PB, Bathi R, Chaudhari S. Prevalence of oral mucosal lesions in dental patients with tobacco smoking, chewing, and mixed habits: A cross-sectional study in South India. J Family Community Med 2013; 20(2): 130-5.
  19. Lo J, McNaughtan J, Rani V, Maric D, Smith A, McCullough M, et al. An immunohistochemical analysis of cell cycle markers in oral mucosal dysplastic lesions treated by laser therapy. A pilot study. J Maxillofac Oral Surg 2011; 10(3): 190-4.
  20. Dietrich T, Reichart PA, Scheifele C. Clinical risk factors of oral leukoplakia in a representative sample of the US population. Oral Oncol 2004; 40(2): 158-63.
  21. Yang SW, Tsai CN, Lee YS, Chen TA. Treatment outcome of dysplastic oral leukoplakia with carbon dioxide laser--emphasis on the factors affecting recurrence. J Oral Maxillofac Surg 2011; 69(6): e78-e87.
  22. Chandu A, Smith AC. The use of CO2 laser in the treatment of oral white patches: outcomes and factors affecting recurrence. Int J Oral Maxillofac Surg 2005; 34(4): 396-400.
  23. Starzynska A, Pawlowska A, Renkielska D, Michajlowski I, Sobjanek M, Blazewicz I. Oral premalignant lesions: epidemiological and clinical analysis in the northern Polish population. Postepy Dermatol Alergol 2014; 31(6): 341-50.
  24. Liu W, Shi LJ, Wu L, Feng JQ, Yang X, Li J, et al. Oral cancer development in patients with leukoplakia – clinicopathological factors affecting outcome. PLoS One 2012; 7(4): e34773.
  25. Lee JJ, Hung HC, Cheng SJ, Chen YJ, Chiang CP, Liu BY, et al. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101(4): 472-80.
  26. Lederman M. Epi-oesophageal cancer with special reference to tumours of the post cricoid region. Br J Radiol 1955; 28(328): 173-83.
  27. Mashberg A, Meyers H. Anatomical site and size of 222 early asymptomatic oral squamous cell carcinomas: a continuing prospective study of oral cancer. II. Cancer 1976; 37(5): 2149-57.
  28. Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol 2006; 42(5): 461-74.
  29. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 2008; 37(1): 1-10.
  30. Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis. Head Neck 2009; 31(12): 1600-9.
  31. Banoczy J, Csiba A. Occurrence of epithelial dysplasia in oral leukoplakia. Analysis and follow-up study of 12 cases. Oral Surg Oral Med Oral Pathol 1976; 42(6): 766-74.
  32. Saito T, Sugiura C, Hirai A, Notani K, Totsuka Y, Shindoh M, et al. Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg 2001; 30(1): 49-53.
  33. Silverman S, Bhargava K, Smith LW, Malaowalla AM. Malignant transformation and natural history of oral leukoplakia in 57,518 industrial workers of Gujarat, India. Cancer 1976; 38(4): 1790-5.
  34. Vedtofte P, Holmstrup P, Hjorting-Hansen E, Pindborg JJ. Surgical treatment of premalignant lesions of the oral mucosa. Int J Oral Maxillofac Surg 1987; 16(6): 656-64.
  35. Pandey M, Thomas G, Somanathan T, Sankaranarayanan R, Abraham EK, Jacob BJ, et al. Evaluation of surgical excision of non-homogeneous oral leukoplakia in a screening intervention trial, Kerala, India. Oral Oncol 2001; 37(1): 103-9.
  36. Hogewind WF, van der Kwast WA, van der Waal I. Oral leukoplakia, with emphasis on malignant transformation. A follow-up study of 46 patients. J Craniomaxillofac Surg 1989; 17(3): 128-33.
  37. Hsue SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med 2007; 36(1): 25-9.
  38. del Corso G, Gissi DB, Tarsitano A, Costabile E, Marchetti C, Montebugnoli L, et al. Laser evaporation versus laser excision of oral leukoplakia: A retrospective study with long-term follow-up. J Craniomaxillofac Surg 2015; 43(6): 763-8.
  39. Yeh CJ. Simple cryosurgical treatment for oral lesions. Int J Oral Maxillofac Surg 2000; 29(3): 212-6.
  40. Kawczyk-Krupka A, Bugaj AM, Latos W, Zaremba K, Sieron A. Photodynamic therapy in treatment of cutaneous and choroidal melanoma. Photodiagnosis Photodyn Ther 2013; 10(4): 503-9.
  41. Yu CH, Chen HM, Chang CC, Hung HY, Hsiao CK, Chiang CP. Cotton-swab cryotherapy for oral leukoplakia. Head Neck 2009; 31(8): 983-8.
  42. Lin HP, Chen HM, Cheng SJ, Yu CH, Chiang CP. Cryogun cryotherapy for oral leukoplakia. Head Neck 2012; 34(9): 1306-11.
  43. Schoelch ML, Sekandari N, Regezi JA, Silverman S. Laser management of oral leukoplakias: a follow-up study of 70 patients. Laryngoscope 1999; 109(6): 949-53.
  44. Thomson PJ, Wylie J. Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management. Int J Oral Maxillofac Surg 2002; 31(2): 145-53.
  45. Frame JW. Removal of oral soft tissue pathology with the CO2 laser. J Oral Maxillofac Surg 1985; 43(11): 850-5.
  46. Horch HH, Gerlach KL, Schaefer HE. CO2 laser surgery of oral premalignant lesions. Int J Oral Maxillofac Surg 1986; 15(1): 19-24.
  47. Ishii J, Fujita K, Komori T. Laser surgery as a treatment for oral leukoplakia. Oral Oncol 2003; 39(8): 759-69.
  48. White JM, Chaudhry SI, Kudler JJ, Sekandari N, Schoelch ML, Silverman S. Nd:YAG and CO2 laser therapy of oral mucosal lesions. J Clin Laser Med Surg 1998; 16(6): 299-304.
  49. Lopez-Jornet P, Camacho-Alonso F. Comparison of pain and swelling after removal of oral leukoplakia with CO2 laser and cold knife: A randomized clinical trial. Med Oral Patol Oral Cir Bucal 2013; 18(1): e38-e44.
  50. Vivek V, Jayasree RS, Balan A, Sreelatha KT, Gupta AK. Three-year follow-up of oral leukoplakia after neodymium: yttrium aluminum garnet (Nd:YAG) laser surgery. Lasers Med Sci 2008; 23(4): 375-9.
  51. van der Hem PS, Nauta JM, van der Wal JE, Roodenburg JL. The results of CO2 laser surgery in patients with oral leukoplakia: a 25 year follow up. Oral Oncol 2005; 41(1): 31-7.
  52. Flynn MB, White M, Tabah RJ. Use of carbon dioxide laser for the treatment of premalignant lesions of the oral mucosa. J Surg Oncol 1988; 37(4): 232-4.
  53. Chiesa F, Tradati N, Sala L, Costa L, Podrecca S, Boracchi P, et al. Follow-up of oral leukoplakia after carbon dioxide laser surgery. Arch Otolaryngol Head Neck Surg 1990; 116(2): 177-80.
  54. Roodenburg JL, Panders AK, Vermey A. Carbon dioxide laser surgery of oral leukoplakia. Oral Surg Oral Med Oral Pathol 1991; 71(6): 670-4.
  55. Lim B, Smith A, Chandu A. Treatment of oral leukoplakia with carbon dioxide and potassium-titanyl-phosphate lasers: a comparison. J Oral Maxillofac Surg 2010; 68(3): 597-601.
  56. Mogedas-Vegara A, Hueto-Madrid JA, Chimenos-Kustner E, Bescos-Atin C. The treatment of oral leukoplakia with the CO2 laser: A retrospective study of 65 patients. J Craniomaxillofac Surg 2015; 43(5): 677-81.
  57. Carnelio S, Rodrigues G, Shenoy R, Fernandes D. A brief review of common oral premalignant lesions with emphasis on their management and cancer prevention. Indian J Surg 2011; 73(4): 256-61.
  58. Abidullah M, Kiran G, Gaddikeri K, Raghoji S, Ravishankar TS. Leuloplakia - Review of a potentially malignant disorder. J Clin Diagn Res 2014; 8(8): ZE01-ZE04.
  59. Pindborg J, Reichart PA, Smith CJ, van der Waal I. Histological typing of cancer and precancer of the oral mucosa. 2nd ed. Berlin, Germany: Springer; 1997.
  60. Brouns ER, Baart JA, Bloemena E, Karagozoglu H, van der Waal I. The relevance of uniform reporting in oral leukoplakia: definition, certainty factor and staging based on experience with 275 patients. Med Oral Patol Oral Cir Bucal 2013; 18(1): e19-e26.
  61. Warnakulasuriya S. Histological grading of oral epithelial dysplasia: revisited. J Pathol 2001; 194(3): 294-7.
  62. Brennan M, Migliorati CA, Lockhart PB, Wray D, Al-Hashimi I, Axell T, et al. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103(Suppl): S19.e1–S19.e12.
  63. Messadi DV. Diagnostic aids for detection of oral precancerous conditions. Int J Oral Sci 2013; 5(2): 59-65.
  64. Ribeiro AS, Salles PR, da Silva TA, Mesquita RA. A review of the nonsurgical treatment of oral leukoplakia. Int J Dent 2010; 2010: 186018.
  65. Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 2005; 65(17): 8017-21.
  66. Nair DR, Pruthy R, Pawar U, Chaturvedi P. Oral cancer: Premalignant conditions and screening--an update. J Cancer Res Ther 2012; 8(Suppl 1): S57-S66.
  67. van der Waal I, Schepman KP, van der Meij EH, Smeele LE. Oral leukoplakia: a clinicopathological review. Oral Oncol 1997; 33(5): 291-301.
  68. Rosenberg D, Cretin S. Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol 1989; 67(5): 621-7.
  69. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996; 56(11): 2488-92.
  70. Rosin MP, Cheng X, Poh C, Lam WL, Huang Y, Lovas J, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 2000; 6(2): 357-62.
  71. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54(18): 4855-78.
  72. Shahnavaz SA, Regezi JA, Bradley G, Dube ID, Jordan RC. p53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas. J Pathol 2000; 190(4): 417-22.
  73. Murti PR, Warnakulasuriya KA, Johnson NW, Bhonsle RB, Gupta PC, Daftary DK, et al. p53 expression in oral precancer as a marker for malignant potential. J Oral Pathol Med 1998; 27(5): 191-6.
  74. Kushner J, Bradley G, Jordan RC. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth. J Pathol 1997; 183(4): 418-23.
  75. Dabelsteen E, Mandel U, Clausen H. Cell surface carbohydrates are markers of differentiation in human oral epithelium. Crit Rev Oral Biol Med 1991; 2(4): 493-507.
  76. Chu FW, Silverman S, Dedo HH. CO2 laser treatment of oral leukoplakia. Laryngoscope 1988; 98(2): 125-30.
  77. Chee M, Sasaki C. Carbon dioxide laser fiber for the excision of oral leukoplakia. Ann Otol Rhinol Laryngol 2013; 122(9): 547-9.
  78. Tuncer I, Ozcakir-Tomruk C, Sencift K, Cologlu S. Comparison of conventional surgery and CO2 laser on intraoral soft tissue pathologies and evaluation of the collateral thermal damage. Photomed Laser Surg 2010; 28(1): 75-9.
  79. Yardimci G, Kutlubay Z, Engin B, Tuzun Y. Precancerous lesions of oral mucosa. World J Clin Cases 2014; 2(12): 866-72.
  80. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev 2006; (4): CD001829.
  81. Bansal A, Jain S, Gupta S. Cryosurgery in the treatment of oro-facial lesions. Indian J Dent Res 2012; 23(2): 297.
  82. Amaral WJ, Frost JR, Howard WR, Cheatham JL. Cryosurgery in treatment of inflammatory papillary hyperplasia. Oral Surgery, Oral Medicine, Oral Pathology 1968; 25(4): 648-54.
  83. Ben-Bassat M, Kaplan I, Shindel Y, Edlan A. The CO2 laser in surgery of the tongue. Br J Plast Surg 1978; 31(2): 155-6.
  84. Gaspar L. The use of the high power lasers in oral surgery. Acta Biomed Ateneo Parmense 1992; 63(1-2): 85-95.
  85. Goodson ML, Sugden K, Kometa S, Thomson PJ. Complications following interventional laser surgery for oral cancer and precancerous lesions. Br J Oral Maxillofac Surg 2012; 50(7): 597-600.
  86. Lee JJ, Hung HC, Cheng SJ, Chiang CP, Liu BY, Yu CH, et al. Factors associated with underdiagnosis from incisional biopsy of oral leukoplakic lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104(2): 217-25.
  87. Slaughter DP, Southwick HW, SmejkaL W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6(5): 963-8.
  88. Epstein JB, Gorsky M, Fischer D, Gupta A, Epstein M, Elad S. A survey of the current approaches to diagnosis and management of oral premalignant lesions. J Am Dent Assoc 2007; 138(12): 1555-62.